Dec 6- U.S. regulators on Friday approved Gilead Sciences Inc's Sovaldi, also known as sofosbuvir, as a potential cure for chronic infection with the liver-destroying hepatitis C virus. Most patients will be treated with the $7,000- a-week drug for 12 weeks, resulting in a total price of $84,000, according to Gilead spokeswoman Cara Miller.» Read More
Immigration policies are turning away high-skilled entrepreneurs from other countries — at a big cost to our economy, says guest columnist Dane Stangler.
More than 90 percent of job creation at venture-backed companies occurs after an IPO. Guest Columnist Terry McGuire looks at ways to get more companies to market.
America was founded on the backs of great entrepreneurs, and it will only continue to flourish if we champion entrepreneurship moving forward, says venture capitalist Mo Koyfman.
Can India transition from being the favored destination for offshored services to a locus of innovation?
While some believe government intervention in health-care reform is the only way forward, there are already health-care organizations around the country that can deliver better quality care at a lower cost.
Many would-be innovators have misconceptions about the process of innovation itself. Here, we review some common myths of innovation and separate fiction from fact.
America is in the midst of physical decline. Decades of infrastructure neglect are eroding centuries of economic progress. Call it: The Great Regression.
A Booz & Company study found that companies whose innovation strategies are clearly aligned with their business and culture goals delivered 17-percent higher profit growth over five-year periods than those lacking such tight alignment.
CNBC's Seema Mody has the story on an intuitive technology for surgeons.
With so much need that must be met, businesses with that “bigger is always better” mentality are struggling with how to capture all of the opportunity.
Discussing opportunities for start-up companies in the United States, and the barriers entrepreneurs encounter when creating new products, with Sonja Hoel Perkins, Menlo Ventures managing partner.
CNBC's Tyler Mathisen reports on the passing of Apple's founder, Steve Jobs, and a look back on the competitive relationship between Microsoft's Bill Gates and Apple's Steve Jobs, with CNBC's Jon Fortt. Also reaction to the passing of Jobs and Apple's vision for the next five years, with Arik Hesseldahl, AllThingsD, and CNBC's Herb Greenberg.
CNBC's Jon Fortt talks with Oracle's president, Mark Hurd on the company's future in computer hardware.
CNBC's Jon Fortt has the story behind the tumultuous day in tech, with HP hiring Goldman Sachs to defend against possible activist investors, AMD lowering its revenue guidance and the war of words between Oracle and Autonomy.
R.J. Hottovy, Morningstar analyst, and Harry Rady, Rady Asset Management, discuss Amazon's new tablet, the "Fire," and whether it's the ultimate Trojan horse for Amazon's retail business.
Real innovation isn’t common in higher education, especially at the most prestigious schools.
Discussing how to bring innovation to the classroom with a video-game learning resource for K-12 students, with Ntiedo Etuk, DimensionU CEO/co-founder and Sal Khan, The Khan Academy founder.
A look at how innovation can impact the future of education, with CNBC's Michelle Caruso-Cabrera; Nancy Peretsman, Allen & Co.managing director; and Ted Mitchell, NewSchools Venture fund CEO.
The U.S. ranks 31st of 56 countries in advanced math skills. Discussing whether the U.S. can compete globally and how to fix our education system, with Arne Duncan, U.S. Secretary of Education.